Skip to main content

Consumer

By Jonah Comstock | 03:40 pm | April 27, 2018
The Yelp for doctors that consumers have been waiting for might just be Yelp itself, according to a new report from the Manhattan Institute released last week and presented today at Health Datapalooza in Washington, DC.
By Jonah Comstock | 12:34 pm | April 26, 2018
This Saturday, the United States Drug Enforcement Agency (DEA) will host its third National Prescription Drug Take Back Day.
By Jonah Comstock | 04:39 pm | April 25, 2018
Telemedicine company American Well and health technology company Royal Philips anounced back in January that they would partner to integrate American Well's virtual care capabilites into Philips' consumer and professional digital health products.
By Laura Lovett | 04:17 pm | April 20, 2018
Forty mph winds pelted cold rain against the runners as they approached the Boston Marathon’s infamous Heartbreak Hill.
By Jonah Comstock | 04:11 pm | April 18, 2018
San Francisco-based PeerWell has added an augmented reality feature to its app, which helps post-surgical patients manage their recovery.
By Dave Muoio | 04:08 pm | April 18, 2018
Stockholm, Sweden-based respiratory monitor maker NuvoAir (formerly Pond Healthcare Innovation) has unveiled the newest version of its home-use spirometer.
By Mike Miliard | 05:22 pm | April 17, 2018
The Defense Advanced Research Projects Agency awarded a $5.
By Jonah Comstock | 03:42 pm | April 12, 2018
Personal genomics company Helix announced two new partnerships this week, both of which take the company — which has focused on ancestry and lifestyle applications in the past — strongly into the clinical realm.
By Laura Lovett | 01:18 pm | April 12, 2018
When stress levels are high, turning to an app for guided meditation might not be all that effective, according to a recent small study published in BMC Psychology.
By Jonah Comstock | 05:24 pm | April 09, 2018
Things aren't getting any better for Outcome Health, the digital health media company that recently settled a three-month legal battle over claims that the company misled its investors and defrauded its customers.